Sandesh Mahatme
2020
Compensation breakdown
| Option Awards | $2,244,824 |
|---|---|
| Salary | $312,835 |
| Stock Awards | $766,949 |
| Other | $39,413 |
| Total | $3,364,021 |
Mahatme received $2.2M in option awards, accounting for 67% of the total pay in 2020.
Mahatme also received $312.8K in salary, $766.9K in stock awards and $39.4K in other compensation.
Rankings
In 2020, Sandesh Mahatme's compensation ranked 3,455th out of 13,090 executives tracked by ExecPay. In other words, Mahatme earned more than 73.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,455 out of 13,090 | 74th |
Division Manufacturing | 1,345 out of 5,617 | 76th |
Major group Chemicals And Allied Products | 506 out of 2,248 | 78th |
Industry group Drugs | 439 out of 1,948 | 78th |
Industry Pharmaceutical Preparations | 329 out of 1,453 | 77th |
Pay ratio
| Sandesh Mahatme's Pay | $3,364,021 |
|---|---|
| Median Employee's Pay | $275,247 |
| Pay Ratio | 12to 1 |
In 2020, the annual total compensation of Sandesh Mahatme was $3,364,021.
The annual total compensation of the median employee at Sarepta Therapeutics was $275,247.
The ratio of Sandesh Mahatme's pay to the pay of median employee was therefore 12 to one.
Mahatme's colleagues
We found seven more compensation records of executives who worked with Sandesh Mahatme at Sarepta Therapeutics in 2020.
2020
Louise Rodino-Klapac
Sarepta Therapeutics
Chief Scientific Officer
2020
David Howton
Sarepta Therapeutics
General Counsel
2020
Ian Estepan
Sarepta Therapeutics
Chief Financial Officer
2020
Gilmore MMSc
Sarepta Therapeutics
Chief Scientific Officer
2020
Douglas Ingram
Sarepta Therapeutics
Chief Executive Officer
2020
Joseph Bratica
Sarepta Therapeutics
Vice President, Corporate Controller
2020
William Ciambrone
Sarepta Therapeutics